The article reviews the importance of IL-6 in cardiac metabolic homeostasis and possible underlying mechanisms, hoping to provide new insights into therapeutic potential of IL-6 in targeting cardiac diseases caused by metabolic disorder. This evidence concerns the gene IL6 and Other metabolic disease.